Delivery Order SPE2DB22D2206-SPE2DB25FKE38
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,697.77 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $28,074.21 on September 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,692.22 for Myrbetriq ER 50 mg tablets (90-count supply) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,993.83 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count). This firm fixed price, non-set-aside contract was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,550.59 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units), with an ultimate completion date of July 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,045.67 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.51 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply). This firm fixed-price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,783.17 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $12,964.22 to AmerisourceBergen Drug Corp for supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed price contract. This non-set-aside delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKE38Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $71,629.48 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed price contract. This non-set-aside award was executed on September 29, 2025, with an ultimate completion date of September 30, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order as part of its broader role in supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The DLA Troop Support's planned Pharmaceutical Prime Vendor Global Program Generation V contracts are expected to include multiple regional awards involving at least three contractors, positioning AmerisourceBergen Drug Corp to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.6k | 9/29/25 |